Skip to main content
HR 7473 117th Congress House Health

Generic Substitution Noninterference Act

Introduced: April 7, 2022 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 1, 2022
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Apr 7, 2022
Referred to the House Committee on the Judiciary.
Apr 7, 2022
Introduced in House
 Plain-English summary Congressional Research Service

Generic Substitution Noninterference Act

This bill prohibits drug manufacturers from helping or directing health care providers to limit prescriptions to brand-name drugs when generic versions are available. The Federal Trade Commission and states may enforce this bill through civil actions.

What's happening now November 1, 2022

Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

 Committees of jurisdiction 2